MHRA disallows epilepsy drug Topiramate use for pregnant patientsLondon, 21 June 2024: The UK Medicines and Healthcare products Regulatory Agency (MHRA) is introducing new safety measures for topiramate after a study has shown an increased risk of neurodevelopmental disabilities in children whose mothers took the drug during pregnancy.
View Details
MHRA disallows epilepsy drug Topiramate use for pregnant patients
London, 21 June 2024: The UK Medicines and Healthcare products Regulatory Agency (MHRA) is introducing new safety measures for topiramate after a study has shown an increased risk of neurodevelopmental disabilities in children whose mothers took the drug during pregnancy. View Details
